Pierre Van Antwerpen
0000-0002-4934-8863
Université Libre de Bruxelles
47 papers found
Refreshing results…
In vitro anticancer activity, toxicity and structure-activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii.
Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography-tandem mass spectrometry for the future study of its posttranslational modifications.
Utility of screen printed electrodes for in vitro metabolic stability assays: Application to acetaminophen and its thioconjugates
Benefits of napping and an extended duration of recovery sleep on alertness and immune cells after acute sleep restriction.
Copper and myeloperoxidase-modified LDLs activate Nrf2 through different pathways of ROS production in macrophages.
Structure-Based Design, Synthesis, and Pharmacological Evaluation of 3-(Aminoalkyl)-5-fluoroindoles as Myeloperoxidase Inhibitors
Free radical-scavenging, antioxidant and immunostimulating effects of a licorice infusion (Glycyrrhiza glabra L.)
Enzyme Immobilized Magnetic Nanoparticles for in-line Capillary Electrophoresis and Drug Biotransformation Studies: Application to Paracetamol
Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha.
Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli.
Coronary stenting is associated with an acute increase in plasma myeloperoxidase in stable angina patients but not in patients with acute myocardial infarction.
Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients
A large-bolus injection, but not continuous infusion of sodium selenite improves outcome in peritonitis.
A new easy method for specific measurement of active myeloperoxidase in human biological fluids and tissue extracts
Cardiovascular diseases, erectile dysfunction and myeloperoxidase | Maladies cardiovasculaires, dysfonction érectile et myéloperoxydase
Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme.
Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification
Monocyte-platelet complexes on CD14/CD16 monocyte subsets: relationship with ApoA-I levels. A preliminary study.
Resveratrol inhibits the activity of equine neutrophil Myeloperoxidase by a direct interaction with the enzyme
Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
Missing publications? Search for publications with a matching author name.